(167 days)
No
The description focuses on the physical characteristics and materials of a guidewire and its accessories. There is no mention of software, algorithms, or data processing that would indicate the use of AI/ML.
No.
The Aristotle Colossus Guidewire is primarily designed to facilitate the introduction and positioning of other interventional devices, rather than directly treating a condition itself. It acts as a tool or accessory for interventional procedures, not a therapeutic agent.
No
The device description indicates that the guidewire is used to "introduce and position catheters and other interventional devices," which are procedural functions rather than diagnostic ones. While it facilitates fluoroscopic visualization, this is for guidance during a procedure, not for obtaining diagnostic information about a patient's condition.
No
The device description clearly describes a physical guidewire made of materials like platinum and coated with polymers, along with physical accessories like a shaping mandrel and torque device. It is a hardware device, not software.
Based on the provided information, the Aristotle Colossus Guidewire is not an IVD (In Vitro Diagnostic) device.
Here's why:
- Intended Use: The intended use is to "introduce and position catheters and other interventional devices" within the neuro and peripheral vasculatures. This is a direct medical intervention within the body, not a test performed on samples taken from the body.
- Device Description: The description details a physical guidewire designed for navigation within blood vessels. It's a tool used during a medical procedure.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, tissue, etc.), detecting specific analytes, or providing diagnostic information based on laboratory testing.
IVD devices are used to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. The Aristotle Colossus Guidewire is a surgical/interventional tool used in vivo.
N/A
Intended Use / Indications for Use
The Aristotle Colossus Guidewire is intended for general vascular use within the neuro and peripheral vasculatures to introduce and position catheters and other interventional devices. The guidewire is not intended for use in the coronary vasculature.
Product codes (comma separated list FDA assigned to the subject device)
MOF, DQX
Device Description
Scientia Vascular's Aristotle Colossus Guidewire is a modification of Scientia Vascular's Aristotle 24 Guidewire. It is a 0.035" diameter, steerable guidewire with a shapeable tip to aid in accessing vasculature. The guidewire is supplied sterile and is for single use only. It is provided in a single stiffness profile (standard) and is available in a range of lengths from 150 cm to 300 cm. The distal portion of the guidewire tip includes a radiopaque platinum wire marker coil to facilitate fluoroscopic visualization. The guidewire has a hydrophilic polymer coating on the distal portion and a polytetrafluoroethylene (PTFE) coating on the proximal portion to reduce friction during manipulation in tortuous vessels.
The guidewire is provided with a shaping mandrel, an introducer (to aid with the insertion of the guidewire into a catheter hub and/or a rotating hemostasis valve (RHV)), and a torque device (to attach to the proximal portion of the guidewire to facilitate gripping and manipulation of the guidewire during use). The shaping mandrel, introducer, and torque device accessories are included to facilitate use of the guidewire and are not intended to contact the patient's body.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Fluoroscopic visualization
Anatomical Site
Neuro and peripheral vasculatures
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Physician
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-Clinical Performance Tests:
Biocompatibility: Evaluation in accordance with ISO 10993-1: 2018. Tests performed include Cytotoxicity (MEM Elution), Direct Contact and Extract Method Hemolysis Test, Partial Thromboplastin Time (PTT) Test, Complement Activation of SC5b-9, and Hemocompatibility In-vitro Blood Loop. Key results: Non-cytotoxic, Non-hemolytic, No effect on PTT (similar to predicate), similar or lower potential to activate complement system compared to predicate, thrombogenic risk potential similar to predicate.
Functional Testing: Performance testing after risk assessment per ISO 14971:2012. Functional testing performed per ISO 11070-2014 and AAMI TIR42:2021, as well as FDA Guidance Documents: Coronary, Peripheral, and Neurovascular Guidewires Performance Tests and Recommended Labeling (October 2019) and Intravascular Catheters, Wires and Delivery Systems with Lubricious Coatings Labeling Considerations (October 2019). Tests include Dimensional Verification, Tensile Strength, Fracture and Flexing, Torqueability and Torque Strength, Tip Flexibility, Tip Shape Retention, Coating Lubricity and Durability, Coating Integrity, Particulate, Simulated Use Model Testing and Product Compatibility, Usability Evaluation. Key results: All tests met acceptance criteria.
Sterilization: Evaluated for shelf-life, packaging integrity, sterilization (SAL of at least 10^-6), and EO/ECH residuals and bacterial endotoxin levels.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Aristotle 24 Guidewire (K192783)
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
ASAHI Neurovascular Guide Wire ASAHI CHIKAI Black 18 (K141751)
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.1330 Catheter guide wire.
(a)
Identification. A catheter guide wire is a coiled wire that is designed to fit inside a percutaneous catheter for the purpose of directing the catheter through a blood vessel.(b)
Classification. Class II (special controls). The device, when it is a torque device that is manually operated, non-patient contacting, and intended to manipulate non-cerebral vascular guide wires, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 870.9.
0
January 26, 2023
Image /page/0/Picture/1 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
Scientia Vascular, Inc. Max Alfonso Regulatory Affairs Specialist 3487 West 2100 South, Suite 100 West Valley City, Utah 84119
Re: K222437
Trade/Device Name: Aristotle Colossus Guidewire Regulation Number: 21 CFR 870.1330 Regulation Name: Catheter Guide Wire Regulatory Class: Class II Product Code: MOF, DQX Dated: December 28, 2022 Received: December 29, 2022
Dear Max Alfonso:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's
1
requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Naira Muradyan -S
Naira Muradyan, Ph.D. Assistant Director DHT5A: Division of Neurosurgical, Neurointerventional and Neurodiagnostic Devices OHT5: Office of Neurological and Physical Medicine Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known)
Device Name Aristotle Colossus Guidewire
Indications for Use (Describe)
The Aristotle Colossus Guidewire is intended for general vascular use within the neuro and peripheral vasculatures to introduce and position catheters and other interventional devices. The guidewire is not intended for use in the coronary vasculature.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/1 description: The image features the logo for Scientia. The logo consists of a stylized, teal-colored symbol resembling an abstract "S" or a linked chain, positioned above the word "SCIENTIA" in a gray, futuristic-looking font. The symbol is made up of two parallel lines that curve and overlap, creating a sense of connection or flow.
510(k) SUMMARY (Per 21 CFR 807.92)
SCIENTIA VASCULAR, INC. Aristotle Colossus Guidewire
Submitter Name and Address: Scientia Vascular, Inc. 3487 West 2100 South Suite 100 West Valley City, UT 84119
Contact Person: Max Alfonso Regulatory Affairs Specialist Phone: 1 (888) 385-9016 Email: regulatory(@scientiavascular.com
Date Prepared: January 26, 2023
| Trade Name: | Aristotle Colossus Guidewire |
|---|---|
| Common Name: | Guidewire |
| Classification Name: | Guide, Wire, Catheter, Neurovasculature per 21 CFR 870.1330 |
| Primary Product Code: | MOF |
| Secondary Product Code: | DQX |
| Review Panel: | Neurology |
| Device Class: | Class II device per 21 CFR 870.1330 |
| Predicate Device: | Aristotle 24 Guidewire (K192783) |
| Reference Device: | ASAHI Neurovascular Guide Wire ASAHI CHIKAI Black 18 (K141751) |
DEVICE DESCRIPTION
Scientia Vascular's Aristotle Colossus Guidewire is a modification of Scientia Vascular's Aristotle 24 Guidewire. It is a 0.035" diameter, steerable guidewire with a shapeable tip to aid in accessing vasculature. The guidewire is supplied sterile and is for single use only. It is provided in a single stiffness profile (standard) and is available in a range of lengths from 150 cm to 300 cm. The distal portion of the guidewire tip includes a radiopaque platinum wire marker coil to facilitate fluoroscopic visualization. The guidewire has a hydrophilic polymer coating on the distal portion and a polytetrafluoroethylene (PTFE) coating on the proximal portion to reduce friction during manipulation in tortuous vessels.
The guidewire is provided with a shaping mandrel, an introducer (to aid with the insertion of the
4
guidewire into a catheter hub and/or a rotating hemostasis valve (RHV)), and a torque device (to attach to the proximal portion of the guidewire to facilitate gripping and manipulation of the guidewire during use). The shaping mandrel, introducer, and torque device accessories are included to facilitate use of the guidewire and are not intended to contact the patient's body.
INTENDED USE
The Aristotle Colossus Guidewire is intended for use by a physician to help introduce and position catheters or other interventional devices within the neuro and peripheral vasculature.
INDICATIONS FOR USE
The Aristotle Colossus Guidewire is intended for general vascular use within the neuro and peripheral vasculatures to introduce and position catheters and other interventional devices. The guidewire is not intended for use in the coronary vasculature.
COMPARISON OF TECHNOLOGICAL CHARACTERISTICS
The Aristotle Colossus Guidewire has the:
- Same indications for use. ●
- Same intended use,
- Same operating principle. ●
- Same basic guidewire design, ●
- Same materials, and ●
- Same packaging materials and sterilization process,
as the predicate device.
Shown in the table below is the comparison of technological characteristics for the Aristotle Colossus Guidewire to those of the predicate device, Aristotle 24 Guidewire (K192783), and the reference device, ASAHI Neurovascular Guide Wire ASAHI CHIKAI Black 18 (K141751).
5
| Table 1: Comparison between Subject & Predicate/Reference Device Technological Characteristics
| Note: Differences between subject and predicate devices are bolded | |||
|---|---|---|---|
| Description | Subject Device | ||
| Aristotle Colossus Guidewire | Predicate Device | ||
| Aristotle 24 Guidewire (K192783) | Reference Device | ||
| ASAHI Neurovascular Guide Wire ASAHI | |||
| CHIKAI Black 18 (K141751) | |||
| Indications | |||
| for Use | The Aristotle Colossus Guidewire is | ||
| intended for general vascular use within | |||
| the neuro and peripheral vasculatures to | |||
| introduce and position catheters and | |||
| other interventional devices. The | |||
| guidewire is not intended for use in the | |||
| coronary vasculature. | The Aristotle 24 Guidewire is intended | ||
| for general vascular use within the neuro | |||
| and peripheral vasculatures to introduce | |||
| and position catheters and other | |||
| interventional devices. The guidewire is | |||
| not intended for use in the coronary | |||
| vasculature. | This guide wire is intended to be used in the | ||
| neuro vasculature to facilitate the placement | |||
| and exchange of therapeutic devices such as | |||
| cerebral catheters during intravascular | |||
| therapy. This guide wire is intended for use | |||
| only in the neuro vasculature. | |||
| Intended Use | The Aristotle Colossus Guidewire is | ||
| intended for use by a physician to help | |||
| introduce and position catheters or other | |||
| interventional devices within the neuro | |||
| and peripheral vasculature. | The Aristotle 24 Guidewire is intended | ||
| for use by a physician to help introduce | |||
| and position catheters or other | |||
| interventional devices within the neuro | |||
| and peripheral vasculature. | This guide wire is intended to be used in the | ||
| neuro vasculature to facilitate the placement | |||
| and exchange of therapeutic devices such as | |||
| cerebral catheters during intravascular | |||
| therapy. This guide wire is intended for use | |||
| only in the neuro vasculature. | |||
| Wire | |||
| Diameter | 0.035" (0.88 mm) | 0.024" (0.61 mm) | 0.018" (0.45 mm) |
| Device | |||
| Length | 150 cm to 300 cm | 200 cm | 200 cm |
| Flex Length | 35 cm | 35 cm | 34 cm |
| Tip Type and | |||
| Shape | Straight, shapeable | Straight, shapeable | Round Curve |
| Flexibility | Standard | Support, Standard, Soft | Standard |
| Wire Material | Core wire: Stainless-steel | Core wire: Stainless-steel | Core wire: Stainless-steel |
| Coatings | Distal End: Hydrophilic | Distal End: Hydrophilic | Distal End: Hydrophilic |
| Table 1: Comparison between Subject & Predicate/Reference Device Technological Characteristics | |||
| Note: Differences between subject and predicate devices are bolded | |||
| Description | Subject Device | ||
| Aristotle Colossus Guidewire | Predicate Device | ||
| Aristotle 24 Guidewire (K192783) | Reference Device | ||
| ASAHI Neurovascular Guide Wire ASAHI | |||
| CHIKAI Black 18 (K141751) | |||
| Distal Coated Length: 46 cm | Distal Coated Length: 46 cm | Distal Coated Length: 170 cm | |
| Proximal End: PTFE | Proximal End: PTFE | Proximal End: None | |
| Accessories | Shaping mandrel, guidewire introducer, | ||
| torque device | Shaping mandrel, guidewire introducer, | ||
| torque device | Shaping mandrel, guidewire introducer, | ||
| torque device | |||
| Packaging | |||
| Configuration | Tyvek pouch, carton, shipper box | Tyvek pouch, carton, shipper box | Tyvek pouch, carton, shipper box |
| Sterilization | |||
| Method | 100% Ethylene Oxide (EO) | 100% EO | 100% EO |
| Shelf Life | 1 year | 3 years | 3 years |
6
7
The subject device has the following technological characteristic differences when compared to the predicate device: wire diameter, device length and shelf life. The changes in technological characteristics do not result in new materials used or raise new or different questions of safety and effectiveness, nor do the changes result in introduction of new risks for the subject device.
NON-CLINICAL PERFORMANCE TESTS
Results of tests performed on the Aristotle Colossus Guidewire demonstrate that it met the test acceptance criteria and meets the requirements of relevant standards and FDA guidance documents.
Biocompatibility
The biocompatibility evaluation for the subject device, Aristotle Colossus Guidewire, identified as an externally communicating device with circulating blood contact for a limited duration (≤ 24 hours), was performed in accordance with ISO 10993-1: 2018. The materials used in the manufacture of the subject device Aristotle Colossus Guidewire are identical to those used in the manufacturing of the predicate device Aristotle 24 Guidewire, also manufactured by Scientia Vascular, Inc. (K192783). Therefore, some testing is adopted from K192783. The following are the biocompatibility tests performed on the Aristotle Colossus Guidewire:
| Name of Test | Test Summary | Conclusion of Testing |
|---|---|---|
| Cytotoxicity: MEM | ||
| Elution | Cell culture was observed for cytotoxic | |
| reactivity. | Non-cytotoxic. | |
| Direct Contact and Extract | ||
| Method Hemolysis Test | The difference between the hemolytic | |
| indexes of the subject device and the | ||
| negative control was evaluated. | Non-hemolytic. | |
| Partial Thromboplastin Time | ||
| (PTT) Test | The clotting time was observed for both | |
| the subject device and the predicate. | No effect on the PTT. The two | |
| samples are considered similar. | ||
| Complement Activation of | ||
| SC5b-9 | Comparison of the subject device SC5b-9 | |
| value to the predicate device for all | ||
| exposure times was performed. | The subject device had similar or | |
| lower potential to activate the | ||
| complement system when compared | ||
| to the predicate. | ||
| Hemocompatibility In- vitro | ||
| Blood Loop | The catheters are placed in an in- vitro | |
| blood loop for three runs. | ||
| The thrombus score for the subject | ||
| device and predicate device is observed. | Thrombogenic risk potential similar to | |
| the predicate. |
Functional Testing
Performance testing on the subject device was performed after conducting a risk assessment in accordance with ISO 14971:2012 Medical Devices – Application of Risk Management to Medical Devices. Functional testing was performed in accordance with the following standards:
- ISO 11070-2014 Sterile Single-use Intravascular Introducers, Dilators, and Guidewires; .
- AAMI TIR42:2021 Evaluation of Particulates Associated with Vascular Medical Devices; ● as well as the FDA Guidance Documents:
- Coronary, Peripheral, and Neurovascular Guidewires Performance Tests and Recommended ● Labeling (October 2019):
- Intravascular Catheters, Wires and Delivery Systems with Lubricious Coatings Labeling ●
8
Considerations (October 2019).
Table 3 summarizes the testing performed to demonstrate substantial equivalence of the subject device to the predicate device.
| Table 3: Summary of Subject Device Functional Testing | ||
|---|---|---|
| Test | Test Method Summary | Results |
| Dimensional | ||
| Verification | Tests per ISO 11070: | |
| Dimensional inspection per engineering | ||
| drawings. | The Aristotle Colossus | |
| Guidewires met test | ||
| acceptance criteria. | ||
| Tensile Strength | Tensile testing per ISO 11070. | The Aristotle Colossus |
| Guidewires met test | ||
| acceptance criteria | ||
| Fracture and | ||
| Flexing | Fracture and Flexing tests per ISO 11070. | The Aristotle Colossus |
| Guidewires met test | ||
| acceptance criteria | ||
| Torqueability and | ||
| Torque Strength | Measurement of torque response (average | |
| input to output lag) in an anatomical model. | ||
| Torque turns to failure in an anatomical | ||
| model. | The Aristotle Colossus | |
| Guidewires met test | ||
| acceptance criteria | ||
| Tip Flexibility | Measure force to deflect guidewire tips at 5 | |
| mm, 10 mm, and 20 mm test lengths. | The Aristotle Colossus | |
| Guidewires met test | ||
| acceptance criteria | ||
| Tip Shape, | ||
| Retention | Guidewires must be shapeable and must | |
| retain shaped angle after simulated use. | The Aristotle Colossus | |
| Guidewires met test | ||
| acceptance criteria | ||
| Coating Lubricity | ||
| and Durability | Frictional force of coated guidewires was | |
| determined after simulated use in a tortuous | ||
| path. | The Aristotle Colossus | |
| Guidewires met test | ||
| acceptance criteria | ||
| Coating Integrity | Coating uniformity and integrity were | |
| visually examined on dyed samples after | ||
| simulated use in a tortuous path. | The Aristotle Colossus | |
| Guidewires met test | ||
| acceptance criteria | ||
| Particulate | Particulates of various size ranges counted | |
| after simulated use in a tortuous path. | The Aristotle Colossus | |
| Guidewires met test | ||
| acceptance criteria | ||
| Simulated Use | ||
| Model Testing and | ||
| Product | ||
| Compatibility | Anatomical model designed to simulate the | |
| tortuous anatomy of the neurovasculature was | ||
| used for simulated use testing and product | ||
| compatibility. | The Aristotle Colossus | |
| Guidewires met test | ||
| acceptance criteria | ||
| Usability | ||
| Evaluation | Physicians evaluated subject and predicate | |
| guidewires for various performance | ||
| characteristics in a human cadaver. | The Aristotle Colossus | |
| Guidewires met test | ||
| acceptance criteria |
Sterilization
The Aristotle Colossus Guidewire was evaluated for shelf-life testing, packaging integrity, and sterilization including testing to ensure sterilization assurance levels (SAL) of at least 10°, and testing for EO and ethylene chlorohydrin (ECH) residuals and bacterial endotoxin levels.
9
CONCLUSION
The subject device, Aristotle Colossus Guidewire, has the same intended use, same indications for use, and the same fundamental design, materials, and device features as the predicate device. The differences in technological characteristics have been evaluated through testing and risk evaluation, and do not raise new or different questions of safety and effectiveness, supporting that the subject device is substantially equivalent to the predicate, Aristotle 24 Guidewire.